Currently, anti-inflammatory treatment such as IL-1 receptor blockade, anti-IL-6, and anti-TNF are considered to be promising approaches in the early stage after the onset of sepsis, but it is too costly (Tanaka et al., 2016; Venet and Monneret, 2018). Here, IL6 is linked to Sepsis.